Working on developing disruptive tools to revolutionize eye-care
Danny is a pharmacist-owner since 2002 and President of Gilbert Gobeil Martel Pharmacies, which is comprised of four pharmacies and 125 employees. Over the years, Danny has built a strong expertise in marketing, sales and business operations. He is also an active private investor in the healthcare sector.
Board of directors
Dr. Ahmed is a leader in novel treatments for glaucoma, cataract, and lens implant surgery. His pioneering work in glaucoma surgery includes developing
Dr. Rajat N Agrawal is President and CEO of Retina Global, a not-for-profit organization addressing retinal diseases in underserved areas of the world, and a Visiting Faculty at the Roski Eye Institute and Dept. of Ophthalmology at the University of Southern California. He is a world-renowned ophthalmologist and retina specialist. He has been involved in developing a number of medical devices, including the ARGUS-II which allows some blind patients to see again, and drugs for the treatment of ocular diseases. He holds a Masters in Regulatory Affairs and works as a consultant for pre-clinical and clinical research, and business and market evaluation. He has been an advisor for investments and acquisitions of early to late stage
Dr Daniel L Chao is an Assistant Professor of Ophthalmology at the Shiley Eye Institute at the University of California, San Diego. He earned a BS in Biomedical Engineering at Virginia Commonwealth University and an M.D. and Ph.D. in Neurosciences at Stanford University. He completed his internship at Santa Clara Valley Medical Center, his ophthalmology residency at the Bascom Palmer Eye Institute, and his vitreoretinal surgery fellowship at the University of California, San Francisco. His research focuses on treatments of retinal diseases such as macular degeneration and diabetic retinopathy. He has participated in many clinical trials and is involved in interdisciplinary collaborations to develop novel imaging modalities and therapeutic approaches for retinal diseases.
Eric is a biomedical engineer with over 20 years of experience in developing and commercializing medical devices and biomedical applications. He is a guest professor at École Polytechnique and ÉTS.